U.S. flag

An official website of the United States government

NM_001134407.3(GRIN2A):c.2050A>G (p.Thr684Ala) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 26, 2014
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000187640.2

Allele description [Variation Report for NM_001134407.3(GRIN2A):c.2050A>G (p.Thr684Ala)]

NM_001134407.3(GRIN2A):c.2050A>G (p.Thr684Ala)

Gene:
GRIN2A:glutamate ionotropic receptor NMDA type subunit 2A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.2
Genomic location:
Preferred name:
NM_001134407.3(GRIN2A):c.2050A>G (p.Thr684Ala)
Other names:
p.T684A:ACA>GCA
HGVS:
  • NC_000016.10:g.9822382T>C
  • NG_011812.2:g.365373A>G
  • NM_000833.5:c.2050A>G
  • NM_001134407.3:c.2050A>GMANE SELECT
  • NM_001134408.2:c.2050A>G
  • NP_000824.1:p.Thr684Ala
  • NP_001127879.1:p.Thr684Ala
  • NP_001127880.1:p.Thr684Ala
  • NC_000016.9:g.9916239T>C
  • NG_011812.1:g.365373A>G
  • NM_000833.3:c.2050A>G
Protein change:
T684A
Links:
dbSNP: rs796052547
NCBI 1000 Genomes Browser:
rs796052547
Molecular consequence:
  • NM_000833.5:c.2050A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001134407.3:c.2050A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001134408.2:c.2050A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000241237GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(Jun 26, 2014)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000241237.11

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

p.Thr684Ala (ACA>GCA): c.2050 A>G in exon 11 of the GRIN2A gene (NM_000833.3). The T684A variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The T684A variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution alters a conserved position in the predicted extracellular loop between the second and third transmembrane domains of the GRIN2A protein, and other missense mutations in this region of the protein have been reported in association with GRIN2A-related disorders, supporting the functional importance of this region of the protein. In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in EPILEPSY panel(s).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 5, 2023